IMMvention Therapeutix, Inc. — Form D
IMMvention Therapeutix, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-10. The offering totals $4.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-01-10
- Form: D
- Accession: 0001837999-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $2.0M
- Remaining: $2.0M
- Investors: 4
- Date of first sale: 2022-12-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-470125
Issuer
- Name: IMMvention Therapeutix, Inc.
- CIK: 0001837999
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 9 Laboratory Drive, DURHAM, NC, 27709
- Phone: 919-593-6230
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Matthew Cohen | Director | New York, NY |
| Anil Goyal | Director | Durham, NC |
| Lev Osherovich | Director | Durham, NC |
| Benjamin Scruggs | Director | Durham, NC |
| Jenny Ting | Director | Durham, NC |
| Mark Velleca | Director | Durham, NC |
| Anil Goyal | Executive Officer | Durham, NC |
| Marilyn Thompson | Executive Officer | Durham, NC |
| Mark Vellaca | Director | RTP, NC |
Other filings by this issuer (2)
More